Development and application of a multi-component LC-MS/MS method for determination of designer benzodiazepines in urine.

New psychoactive substances (NPS) have become an increasing drug problem in the past decade. For detection of NPS, new analytical methods have to be developed, and the methods also have to be updated regularly. This study aimed at developing a multi-component LC-MS/MS method for detection and quantification of 11 NPS of the benzodiazepine sub-class ("designer benzodiazepines") in urine specimens. The method involves dilution of urine with internal standard and hydrolysis of any glucuronide conjugated forms. Separation of the compounds was achieved on a BEH Phenyl column, followed by MS/MS detection in positive electrospray mode. Method validation was performed following the EMA guideline. The method was applied to study the occurrence of designer benzodiazepines in Sweden in 2014-2015, by analysis of 390 samples retrieved from a routine drug testing laboratory. In 40% of these samples, selected based on a positive immunoassay benzodiazepine screening but a negative MS confirmation for the standard set of prescription benzodiazepines, intake of designer benzodiazepines was revealed. These results stress the importance of using and updating confirmation methods to include the increasing number of designer benzodiazepines appearing on the NPS market.

[1]  J. Cano,et al.  Plasma determination of 3-methylclonazepam by capillary gas chromatography. , 1985, Journal of chromatography.

[2]  John F. Davis,et al.  Ultra Performance Liquid Chromatography with Tandem Mass Spectrometry for the Quantitation of Seventeen Sedative Hypnotics in Six Common Toxicological Matrices. , 2015, Journal of analytical toxicology.

[3]  J. Stephenson,et al.  Phenazepam and its effects on driving. , 2013, Journal of analytical toxicology.

[4]  Madeleine Pettersson Bergstrand,et al.  Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes , 2016, Analytical and Bioanalytical Chemistry.

[5]  D. Ekeberg,et al.  Determination of benzodiazepines in ante-mortem and post-mortem whole blood by solid-supported liquid-liquid extraction and UPLC-MS/MS. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  T. Shinozuka,et al.  Case report: Etizolam and its major metabolites in two unnatural death cases. , 2008, Forensic science international.

[7]  T. Scahill,et al.  Kinetics and equilibrium of the reversible alprazolam ring-opening reaction. , 1983, Journal of pharmaceutical sciences.

[8]  V. Auwärter,et al.  Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics. , 2014, Drug testing and analysis.

[9]  M. Nakano,et al.  Reversible ring-opening reactions of nimetazepam and nitrazepam in acidic media at body temperature. , 1980, Journal of pharmaceutical sciences.

[10]  H. Gjerde,et al.  Comparison of drugs used by nightclub patrons and criminal offenders in Oslo, Norway. , 2016, Forensic science international.

[11]  C. Żaba,et al.  Flubromazolam – A new life-threatening designer benzodiazepine , 2016, Clinical toxicology.

[12]  H P Rang,et al.  Rang and Dale's pharmacology , 2012 .

[13]  H. Druid,et al.  Flunitrazepam: an evaluation of use, abuse and toxicity. , 2001, Forensic science international.

[14]  V. Auwärter,et al.  Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine , 2013, Forensic Toxicology.

[15]  A. Helander,et al.  Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays. , 2017, Drug testing and analysis.

[16]  C. Wakasugi,et al.  Simultaneous determination of twelve benzodiazepines in human serum using a new reversed-phase chromatographic column on a 2-microns porous microspherical silica gel. , 1996, Journal of chromatography. B, Biomedical applications.

[17]  A. Helander,et al.  Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project , 2013, Scandinavian journal of clinical and laboratory investigation.

[18]  V. Auwärter,et al.  Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites , 2015, Forensic Toxicology.

[19]  W. Weinmann,et al.  Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  M. Crichton,et al.  Analysis of phenazepam and 3-hydroxyphenazepam in post-mortem fluids and tissues. , 2015, Drug testing and analysis.

[21]  Marcia Constantinou,et al.  A fatal intoxication related to MDPV and pentedrone combined with antipsychotic and antidepressant substances in Cyprus. , 2016, Forensic science international.

[22]  S. Comer,et al.  Polydrug abuse: a review of opioid and benzodiazepine combination use. , 2012, Drug and alcohol dependence.

[23]  T. Kumazawa,et al.  Simple method for the determination of benzodiazepines in human body fluids by high-performance liquid chromatography–mass spectrometry , 2003 .

[24]  I. Ojanperä,et al.  Fatal poisoning in drug addicts in the Nordic countries in 2012. , 2015, Forensic science international.

[25]  Matt Anderson,et al.  European Monitoring Centre for Drugs and Drug Addiction , 2014 .

[26]  T. Shinozuka,et al.  Rapid and simple analysis of oxazolobenzodiazepine drugs in sera by wide-bore capillary gas chromatography with nitrogen-phosphorus detection using on-column methylation , 2006, Forensic Toxicology.

[27]  H. Inoue,et al.  Screening and determination of benzodiazepines in whole blood using solid-phase extraction and gas chromatography/mass spectrometry. , 2000, Forensic science international.

[28]  I. Ojanperä,et al.  Phenazepam abuse in Finland: findings from apprehended drivers, post-mortem cases and police confiscations. , 2012, Forensic science international.

[29]  Olof Beck,et al.  Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  V. Auwärter,et al.  Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics. , 2013, Journal of mass spectrometry : JMS.

[31]  R. Wu,et al.  A sensitive GC-MS procedure for the analysis of flunitrazepam and its metabolites in urine. , 1997, Journal of analytical toxicology.

[32]  A. Helander,et al.  Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. , 2014, Forensic science international.